vimarsana.com

Page 3 - ஜெர்மனி க்ரீஃப்ஸ்‌வால்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

No specific risk factors for clots with AstraZeneca Covid-19 jab

SINGAPORE (Bloomberg/Reuters/AFP): The AstraZeneca Covid-19 vaccine came under the spotlight following reports of rare blood clots, some of them fatal, among some adult vaccine recipients. Concerns about the vaccine centred on an unusual type of blood clot in the brain called cerebral venous sinus thrombosis (CVST). There were also some cases of clots in the abdomen and in the arteries, which occurred together with low levels of blood platelets. The European Medicines Agency said it had reports of 169 cases of the rare clotting disorder out of 34 million doses administered within Europe, roughly one for every 100,000 people under 60 vaccinated. Most occurred in women under 55 and within two weeks of injection.

Women under 60 face higher risk of rare clotting after AstraZeneca Covid-19 shot: German official

BERLIN/ZURICH (REUTERS) - Instances of a very rare clotting condition in women aged under 60 who received AstraZeneca s Covid-19 vaccine were 20 times higher than would normally be expected, Christian Bogdan, a member of Germany s vaccine committee, said on Wednesday (April 7). The EMA conducted an in-depth review of 86 cases, including 18 fatalities. In comparison, four women out of 10,000 would get a blood clot from taking oral contraception. Bogdan did not specify how many cases of blood clots with low blood platelet counts would be expected in a normal population, but said their higher prevalence in one population group over a defined timeframe represented a very clear risk signal .

Covid-19: Italy, Britain suggest age limits for AstraZeneca vaccine but still recommend it

Covid-19: Italy, Britain suggest age limits for AstraZeneca vaccine but still recommend it Reuters © Provided by Khaleej Times Covid-19: Italy, Britain suggest age limits for AstraZeneca vaccine but still recommend it Italy recommended on Wednesday that AstraZeneca s Covid-19 shot only be used on those over 60 and Britain that people under 30 should get an alternative, due to possible links between the vaccine and very rare cases of blood clots. More than a dozen countries have at one time suspended use of the vaccine, which has been given to tens of millions in Europe. But most have resumed, with some, including France, the Netherlands and Germany, recommending a minimum age.

Italy, Britain still recommend AstraZeneca vaccine but suggest age limits

Italy, Britain still recommend AstraZeneca vaccine but suggest age limits
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.